Javascript must be enabled to continue!
Scalable Nuclei Detection in HER2-SISH Whole Slide Images via Fine-Tuned Stardist with Expert-Annotated Regions of Interest
View through CrossRef
Background: Breast cancer remains a critical health concern worldwide, with histopathological analysis of tissue biopsies serving as the clinical gold standard for diagnosis. Manual evaluation of histopathology images is time-intensive and requires specialized expertise, often resulting in variability in diagnostic outcomes. In silver in situ hybridization (SISH) images, accurate nuclei detection is essential for precise histo-scoring of HER2 gene expression, directly impacting treatment decisions. Methods: This study presents a scalable and automated deep learning framework for nuclei detection in HER2-SISH whole slide images (WSIs), utilizing a novel dataset of 100 expert-marked regions extracted from 20 WSIs collected at the University of Malaya Medical Center (UMMC). The proposed two-stage approach combines a pretrained Stardist model with image processing-based annotations, followed by fine tuning on our domain-specific dataset to improve generalization. Results: The fine-tuned model achieved substantial improvements over both the pretrained Stardist model and a conventional watershed segmentation baseline. Quantitatively, the proposed method attained an average F1-score of 98.1% for visual assessments and 97.4% for expert-marked nuclei, outperforming baseline methods across all metrics. Additionally, training and validation performance curves demonstrate stable model convergence over 100 epochs. Conclusions: These results highlight the robustness of our approach in handling the complex morphological characteristics of SISH-stained nuclei. Our framework supports pathologists by offering reliable, automated nuclei detection in HER2 scoring workflows, contributing to diagnostic consistency and efficiency in clinical pathology.
Title: Scalable Nuclei Detection in HER2-SISH Whole Slide Images via Fine-Tuned Stardist with Expert-Annotated Regions of Interest
Description:
Background: Breast cancer remains a critical health concern worldwide, with histopathological analysis of tissue biopsies serving as the clinical gold standard for diagnosis.
Manual evaluation of histopathology images is time-intensive and requires specialized expertise, often resulting in variability in diagnostic outcomes.
In silver in situ hybridization (SISH) images, accurate nuclei detection is essential for precise histo-scoring of HER2 gene expression, directly impacting treatment decisions.
Methods: This study presents a scalable and automated deep learning framework for nuclei detection in HER2-SISH whole slide images (WSIs), utilizing a novel dataset of 100 expert-marked regions extracted from 20 WSIs collected at the University of Malaya Medical Center (UMMC).
The proposed two-stage approach combines a pretrained Stardist model with image processing-based annotations, followed by fine tuning on our domain-specific dataset to improve generalization.
Results: The fine-tuned model achieved substantial improvements over both the pretrained Stardist model and a conventional watershed segmentation baseline.
Quantitatively, the proposed method attained an average F1-score of 98.
1% for visual assessments and 97.
4% for expert-marked nuclei, outperforming baseline methods across all metrics.
Additionally, training and validation performance curves demonstrate stable model convergence over 100 epochs.
Conclusions: These results highlight the robustness of our approach in handling the complex morphological characteristics of SISH-stained nuclei.
Our framework supports pathologists by offering reliable, automated nuclei detection in HER2 scoring workflows, contributing to diagnostic consistency and efficiency in clinical pathology.
Related Results
Human Epidermal Growth Factor Receptor-2(HER-2) expression in Sri Lankan gastric adenocarcinoma patients: An analysis of the concordance of HER2 expression and survival based on silver in-situ hybridization (SISH)
Human Epidermal Growth Factor Receptor-2(HER-2) expression in Sri Lankan gastric adenocarcinoma patients: An analysis of the concordance of HER2 expression and survival based on silver in-situ hybridization (SISH)
Abstract
Background: Accurate HER2 status is crucial for gastric adenocarcinoma (GC) patient selection for antiHER2 therapy. It is assessed immunohistochemically (IHC) for ...
Abstract P4-13-22: Successful targeting HER2 in heavily pretreated HER2-negative metastatic breast cancer patients presenting with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells
Abstract P4-13-22: Successful targeting HER2 in heavily pretreated HER2-negative metastatic breast cancer patients presenting with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells
Abstract
Background: A considerable proportion of patients (pts) with HER2-negative (HER2-) metastatic breast cancer (MBC) present with elevated serum levels of the ...
Abstract P4-15-07: HER2 positive (HER2/CEP17 ratio≥2.0) invasive mammary carcinomas with average <4.0 HER2 and <2.0 CEP17 signals/cell: Clinicopathologic features, correlation with HER2 immunohistochemistry and response to neoadjuvant chemot
Abstract P4-15-07: HER2 positive (HER2/CEP17 ratio≥2.0) invasive mammary carcinomas with average <4.0 HER2 and <2.0 CEP17 signals/cell: Clinicopathologic features, correlation with HER2 immunohistochemistry and response to neoadjuvant chemot
Abstract
Background: ASCO/CAP guidelines for the determination of HER2 amplification have recently been revised in an attempt to clarify which patients will benefit ...
HER2 expression dynamics and prognostic significance in the treatment of gastric cancer.
HER2 expression dynamics and prognostic significance in the treatment of gastric cancer.
4025
Background:
The human epidermal growth factor receptor 2 (HER2) expression undergoes changes during the treatment of gastric canc...
HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and Outcome
HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and Outcome
Abstract
Aims
Apocrine carcinoma of the breast (APO) expresses HER2 in 30-50% of cases. This study explored the clinicopathological features and outcome of HER2+ APO (HER2...
Deep-Learning-Based Approach in Cancer-Region Assessment from HER2-SISH Breast Histopathology Whole Slide Images
Deep-Learning-Based Approach in Cancer-Region Assessment from HER2-SISH Breast Histopathology Whole Slide Images
Fluorescence in situ hybridization (FISH) is widely regarded as the gold standard for evaluating human epidermal growth factor receptor 2 (HER2) status in breast cancer; however, i...
Use of multimodal circulating tumor cell assay to detect HER2-ultralow and ER co-expression matched with single-cell chromosomal instability in metastatic breast cancer.
Use of multimodal circulating tumor cell assay to detect HER2-ultralow and ER co-expression matched with single-cell chromosomal instability in metastatic breast cancer.
e13024
Background:
Breast cancer is the second leading cause of cancer-related mortality among US women, with metastatic breast cancer...
Abstract P3-09-02: The HER2 –positive subtypes by stage and race/ethnicity
Abstract P3-09-02: The HER2 –positive subtypes by stage and race/ethnicity
Abstract
HER2-positivity is often associated with poor survival. The purpose of this study is to determine if there are differences in mortality among the HER-positi...

